Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
- PMID: 40464995
- DOI: 10.1007/s00415-025-13107-y
Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
Erratum for
-
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting.J Neurol. 2024 Dec;271(12):7494-7501. doi: 10.1007/s00415-024-12701-w. Epub 2024 Sep 23. J Neurol. 2024. PMID: 39313638
Publication types
LinkOut - more resources
Full Text Sources